ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.7190-5T>G

dbSNP: rs748245325
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002316606 SCV000666717 uncertain significance Hereditary cancer-predisposing syndrome; Cardiovascular phenotype 2021-05-04 criteria provided, single submitter clinical testing The c.7127-5T>G intronic variant results from a T to G substitution 5 nucleotides upstream from coding exon 48 in the NF1 gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Labcorp Genetics (formerly Invitae), Labcorp RCV000632410 SCV000753589 likely benign Neurofibromatosis, type 1 2024-04-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000632410 SCV002561044 uncertain significance Neurofibromatosis, type 1 2022-03-15 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.